[Bone replacement using beta-tricalcium phosphate--results of experimental studies and initial clinical case examples].
Beta-Tricalcium phosphate granulates (Ceros 82) implanted in femurs of the rat led to osteoconduction already one week after implantation. Compared to the problems of autologous implants, TCP presents many advantages: No operation on the donor site, no limitation of quantity, clinically negligible resorption, immediate osteoconduction. The results on femoral defects of 26 rats filled up by beta-TCP and our first clinical experiences on juvenile bone cysts are presented.